Claims for Patent: 6,683,049

✉ Email this page to a colleague

Summary for Patent: 6,683,049

Title:	Method for treating a cholinergic influenced sweat gland
Abstract:	A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
Inventor(s):	Aoki; K. Roger (Laguna Hill, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (Laguna Niguel, CA), Leon; Judith M. (Laguna Niguel, CA)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	09/490,754
Patent Claims:	1. A method for treating an excessively secreting, cholinergically influenced gland, the method comprising the step of injecting an excessively secreting, cholinergically influenced gland, or to the local area of the gland, with a botulinum toxin in order to reduce an excessive secretory activity of the gland, wherein the gland is a sweat gland. 2. The method of claim 1, wherein the botulinum toxin is botulinum toxin type A. 3. The method of claim 1, wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G. 4. The method of claim 1, wherein the botulinum toxin is administered in an amount of between 0.01 units and 500 units. 5. The method of claim 1, wherein the botulinum toxin is administered in an amount of between 0.01 unit and 50 units. 6. A method for treating an excessively secreting, cholinergically influenced gland, the method comprising the step of injecting an excessively secreting, cholinergic influenced gland or local gland area of a human patient with a therapeutically effective amount of botulinum toxin type A thereby reducing the excessive glandular secretion, wherein the gland is a sweat gland.

Details for Patent 6,683,049

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	BOTOX COSMETIC	onabotulinumtoxina	For Injection	103000	December 09, 1991	⤷ Sign Up	2013-12-28
Abbvie Inc.	BOTOX	onabotulinumtoxina	For Injection	103000	December 09, 1991	⤷ Sign Up	2013-12-28
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 6,683,049

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Australia	1516295	⤷ Sign Up
Australia	688452	⤷ Sign Up
Australia	7010598	⤷ Sign Up
Australia	712502	⤷ Sign Up
Canada	2180011	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.